MedTrace Logo

A Retrospective and Prospective Cohort Study of the 21-day Fasting-like Diet in Patients With Metabolic and Autoimmune Diseases

NCT03193177 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 144

Last updated 2019-09-06

No results posted yet for this study

Summary

Effectiveness of fasting or fasting-mimicking diet has been proved an effective approach to treat metabolic and autoimmune diseases in mice. However, clinical trials performing prolonged fasting with more than 7 days have not been reported. Investigators conduct an open label, phase I/II clinical trial to evaluate the safety and effectiveness of the 21-day fasting-like diet in the treatment of metabolic and autoimmune diseases.

Conditions

Interventions

OTHER

the 21-day fasting-like diet

a fasting-like diet with 400 KJ energy intake per day for 21 days

Sponsors & Collaborators

  • Nanshan Branch of Qilu Hospital

    collaborator UNKNOWN

  • Tsinghua University

    lead OTHER

Principal Investigators

  • Ligang Ming, MD · Nanshan Branch of Qilu Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-20
Primary Completion
2018-08-31
Completion
2018-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03193177 on ClinicalTrials.gov